We are live on ! Find out more
DII

Domini Impact Investments Portfolio holdings

AUM $7.59M
1-Year Est. Return 47.68%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+47.68%
3 Year Est. Return
+231.06%
5 Year Est. Return
+291.89%
10 Year Est. Return
–
AUM
$2.36M
AUM Growth
+$611K
Cap. Flow
+$542K
Cap. Flow %
23.02%
Top 10 Hldgs %
100%
Holding
12
New
3
Increased
7
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$277K
2
SPWR
SunPower Corporation Common Stock
SPWR
+$181K
3
VYNT
Vyant Bio, Inc. Common Stock
VYNT
+$154K
4
NTUS
Natus Medical Inc
NTUS
+$99K
5
STKL
SunOpta
STKL
+$78K

Top Sells

Rank Stock Value
1
ANIK icon
Anika Therapeutics
ANIK
+$245K
2
LWAY icon
Lifeway Foods
LWAY
+$207K

Sector Composition

Rank Sector Weight
1 Healthcare 57.68%
2 Technology 25.68%
3 Consumer Staples 15.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTUS
1
DELISTED
Natus Medical Inc
NTUS
$418K 17.74%
16,644
+4,003
+32% +$99K
OSUR icon
2
OraSure Technologies
OSUR
$273M
$374K 15.87%
43,402
+10,439
+32% +$73.2K
STKL
3
DELISTED
SunOpta
STKL
$368K 15.62%
26,135
+6,286
+32% +$78K
GILD icon
4
Gilead Sciences
GILD
$161B
$295K 12.52%
+3,555
New +$277K
FSLR icon
5
First Solar
FSLR
$21.8B
$277K 11.76%
3,894
+927
+31% +$61.4K
SPWR
6
DELISTED
SunPower Corporation Common Stock
SPWR
$222K 9.42%
+8,279
New +$181K
VYNT
7
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$137K 5.81%
+81
New +$154K
VERU icon
8
Veru
VERU
$36.1M
$135K 5.73%
2,455
+586
+31% +$38.2K
MITK icon
9
Mitek Systems
MITK
$762M
$106K 4.5%
31,793
+7,589
+31% +$25.9K
RGDX
10
DELISTED
RESPONSE GENETICS, INC COMMON SHS (DELAWARE)
RGDX
$24K 1.02%
26,495
+6,348
+32% +$6.64K
ANIK icon
11
Anika Therapeutics
ANIK
$199M
– –
-5,955
Closed -$245K
LWAY icon
12
Lifeway Foods
LWAY
$465M
– –
-14,082
Closed -$207K

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
PIM
Partner Investment Management San Francisco, California $13.9M AUM 55.92% 1-Year Est. Return
MCM
Marcato Capital Management San Francisco, California $1.2M AUM 91.17% 1-Year Est. Return
SLI
Symetra Life Insurance Bellevue, Washington $512K AUM
CWSR
Chessman Wealth Strategies RIA Dallas, Texas $211K AUM 15.56% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return

Domini Impact Investments's Q2 2014 Portfolio in Review

As of Q2 2014, Domini Impact Investments held 12 positions worth $2.36M, up 35% from $1.75M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Domini Impact Investments deployed $542K of net new capital in Q2 2014, opening 3 new positions and adding to 7 existing holdings. Its largest new stake was Gilead Sciences: 3,555 shares worth $295K.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 56% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the most notable exit was Anika Therapeutics, an estimated $245K sold.

  • Domini Impact Investments's largest Q2 2014 buy was Gilead Sciences: 3,555 shares worth $295K.
  • Domini Impact Investments added most to Natus Medical Inc in Q2 2014, an estimated $99K increase.
  • Domini Impact Investments fully exited Anika Therapeutics in Q2 2014, selling an estimated $245K.
  • Domini Impact Investments's ten largest holdings make up 100% of its $2.36M portfolio in Q2 2014.
  • Domini Impact Investments opened 3 new positions and closed 2 in Q2 2014.
  • Domini Impact Investments's portfolio value rose 35% quarter-over-quarter to $2.36M.

Based on Domini Impact Investments's 13F filing for Q2 2014, filed 8 Aug 2014.